Index by author

01 November 2010; volume 36, issue 5

A

  1. Aarbiou, J.

    1. Dif, F. et al "Critical role of cytosolic phospholipase A2α in bronchial mucus hypersecretion in CFTR-deficient mice." European Respiratory Journal 36.5 (2010): 1120-1130. Web. 21 June. 2021.

  2. Abramowicz, D.

    1. Naeije, R. et al "Pulmonary artery pressure limits exercise capacity at high altitude." European Respiratory Journal 36.5 (2010): 1049-1055. Web. 21 June. 2021.

  3. Adcock, I.M.

    1. Mortaz, E. et al "Cigarette smoke induces CXCL8 production by human neutrophils via activation of TLR9 receptor." European Respiratory Journal 36.5 (2010): 1143-1154. Web. 21 June. 2021.

  4. Agustí, M.

    1. Almirall, J. et al "Inhaled drugs as risk factors for community-acquired pneumonia." European Respiratory Journal 36.5 (2010): 1080-1087. Web. 21 June. 2021.

  5. Aït Khaled, N.

    1. Bousquet, J. et al "Prioritised research agenda for prevention and control of chronic respiratory diseases." European Respiratory Journal 36.5 (2010): 995-1001. Web. 21 June. 2021.

  6. Aliverti, A.

    1. Aliverti, A., A. Lo Mauro, and M.G. D'Angelo. "From the authors:." European Respiratory Journal 36.5 (2010): 1223. Web. 21 June. 2021.

  7. Almirall, J.

    1. Almirall, J. et al "Inhaled drugs as risk factors for community-acquired pneumonia." European Respiratory Journal 36.5 (2010): 1080-1087. Web. 21 June. 2021.

  8. Arizono, S.

    1. Nishiyama, O. et al "A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis." European Respiratory Journal 36.5 (2010): 1067-1072. Web. 21 June. 2021.

  9. Aukrust, P.

    1. Eagan, T.M.L. et al "Body composition and plasma levels of inflammatory biomarkers in COPD." European Respiratory Journal 36.5 (2010): 1027-1033. Web. 21 June. 2021.

  10. Ayuso, P.

    1. Almirall, J. et al "Inhaled drugs as risk factors for community-acquired pneumonia." European Respiratory Journal 36.5 (2010): 1080-1087. Web. 21 June. 2021.

B

  1. Baena-Cagnani, C.E.

    1. Bousquet, J. et al "Prioritised research agenda for prevention and control of chronic respiratory diseases." European Respiratory Journal 36.5 (2010): 995-1001. Web. 21 June. 2021.

  2. Bakke, P.S.

    1. Eagan, T.M.L. et al "Body composition and plasma levels of inflammatory biomarkers in COPD." European Respiratory Journal 36.5 (2010): 1027-1033. Web. 21 June. 2021.

  3. Balder, B.

    1. Glader, P. et al "Interleukin-17-producing T-helper cells and related cytokines in human airways exposed to endotoxin." European Respiratory Journal 36.5 (2010): 1155-1164. Web. 21 June. 2021.

  4. Bara, I.

    1. Bara, I. et al "Pathophysiology of bronchial smooth muscle remodelling in asthma." European Respiratory Journal 36.5 (2010): 1174-1184. Web. 21 June. 2021.

  5. Barnes, P.J.

    1. Paredi, P. et al "In memoriam Michael Goldman (1936–2010)." European Respiratory Journal 36.5 (2010): 977-978. Web. 21 June. 2021.

  6. Barreto, M.L.

    1. Bousquet, J. et al "Prioritised research agenda for prevention and control of chronic respiratory diseases." European Respiratory Journal 36.5 (2010): 995-1001. Web. 21 June. 2021.

  7. Bartalesi, F.

    1. Solovic, I. et al "The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement." European Respiratory Journal 36.5 (2010): 1185-1206. Web. 21 June. 2021.

  8. Bärtsch, P.

    1. Corvinus, C. et al "Pulmonary hypertension in a patient with Abt–Letterer–Siwe syndrome and episodes of HAPE." European Respiratory Journal 36.5 (2010): 1212-1214. Web. 21 June. 2021.

  9. Bateman, E.D.

    1. Bousquet, J. et al "Prioritised research agenda for prevention and control of chronic respiratory diseases." European Respiratory Journal 36.5 (2010): 995-1001. Web. 21 June. 2021.

  10. Bauer, C.M.T.

    1. Gaschler, G.J. et al "Mechanisms of clearance of nontypeable Haemophilus influenzae from cigarette smoke-exposed mouse lungs." European Respiratory Journal 36.5 (2010): 1131-1142. Web. 21 June. 2021.

  11. Beezhold, D.H.

    1. Cummings, K.J. et al "Adverse respiratory outcomes associated with occupational exposures at a soy processing plant." European Respiratory Journal 36.5 (2010): 1007-1015. Web. 21 June. 2021.

  12. Belmonte, Y.

    1. Luján, M. et al "Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia." European Respiratory Journal 36.5 (2010): 1073-1079. Web. 21 June. 2021.

  13. Belvisi, M.G.

    1. Birrell, M.A., A.J.M. Van Oosterhout, and M.G. Belvisi. "Do the current house dust mite-driven models really mimic allergic asthma?." European Respiratory Journal 36.5 (2010): 1220-1221. Web. 21 June. 2021.

  14. Berger, P.

    1. Bara, I. et al "Pathophysiology of bronchial smooth muscle remodelling in asthma." European Respiratory Journal 36.5 (2010): 1174-1184. Web. 21 June. 2021.

  15. Billo, N.

    1. Bousquet, J. et al "Prioritised research agenda for prevention and control of chronic respiratory diseases." European Respiratory Journal 36.5 (2010): 995-1001. Web. 21 June. 2021.

  16. Birrell, M.A.

    1. Birrell, M.A., A.J.M. Van Oosterhout, and M.G. Belvisi. "Do the current house dust mite-driven models really mimic allergic asthma?." European Respiratory Journal 36.5 (2010): 1220-1221. Web. 21 June. 2021.

  17. Blachere, F.M.

    1. Cummings, K.J. et al "Adverse respiratory outcomes associated with occupational exposures at a soy processing plant." European Respiratory Journal 36.5 (2010): 1007-1015. Web. 21 June. 2021.

  18. Bledsoe, T.

    1. Cummings, K.J. et al "Adverse respiratory outcomes associated with occupational exposures at a soy processing plant." European Respiratory Journal 36.5 (2010): 1007-1015. Web. 21 June. 2021.

  19. Bolíbar, I.

    1. Almirall, J. et al "Inhaled drugs as risk factors for community-acquired pneumonia." European Respiratory Journal 36.5 (2010): 1080-1087. Web. 21 June. 2021.

  20. Borot, F.

    1. Dif, F. et al "Critical role of cytosolic phospholipase A2α in bronchial mucus hypersecretion in CFTR-deficient mice." European Respiratory Journal 36.5 (2010): 1120-1130. Web. 21 June. 2021.

  21. Boss, H.

    1. Nave, R. et al "Deposition and metabolism of inhaled ciclesonide in the human lung." European Respiratory Journal 36.5 (2010): 1113-1119. Web. 21 June. 2021.

  22. Bossink, A.

    1. Solovic, I. et al "The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement." European Respiratory Journal 36.5 (2010): 1185-1206. Web. 21 June. 2021.

  23. Bousquet, J.

    1. Bousquet, J. et al "Prioritised research agenda for prevention and control of chronic respiratory diseases." European Respiratory Journal 36.5 (2010): 995-1001. Web. 21 June. 2021.

  24. Bowman, M.R.

    1. Chen, H. et al "FIZZ1 potentiates the carbachol-induced tracheal smooth muscle contraction." European Respiratory Journal 36.5 (2010): 1165-1173. Web. 21 June. 2021.

  25. Burgel, P-R.

    1. Dif, F. et al "Critical role of cytosolic phospholipase A2α in bronchial mucus hypersecretion in CFTR-deficient mice." European Respiratory Journal 36.5 (2010): 1120-1130. Web. 21 June. 2021.

  26. Bush, A.

    1. Bush, A., and J. Davies. "Cystic fibrosis: to ion transport and beyond." European Respiratory Journal 36.5 (2010): 991-992. Web. 21 June. 2021.

C

  1. Canonica, G.W.

    1. Bousquet, J. et al "Prioritised research agenda for prevention and control of chronic respiratory diseases." European Respiratory Journal 36.5 (2010): 995-1001. Web. 21 June. 2021.

  2. Carandell, E.

    1. Almirall, J. et al "Inhaled drugs as risk factors for community-acquired pneumonia." European Respiratory Journal 36.5 (2010): 1080-1087. Web. 21 June. 2021.

  3. Carlsen, K-H.

    1. Bousquet, J. et al "Prioritised research agenda for prevention and control of chronic respiratory diseases." European Respiratory Journal 36.5 (2010): 995-1001. Web. 21 June. 2021.

  4. Carmona, L.

    1. Solovic, I. et al "The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement." European Respiratory Journal 36.5 (2010): 1185-1206. Web. 21 June. 2021.

  5. Cernigliaro, A.

    1. Fano, V. et al "The fear of volcano: short-term health effects after Mount Etna's eruption in 2002." European Respiratory Journal 36.5 (2010): 1216-1218. Web. 21 June. 2021.

  6. Chavannes, N.

    1. Bousquet, J. et al "Prioritised research agenda for prevention and control of chronic respiratory diseases." European Respiratory Journal 36.5 (2010): 995-1001. Web. 21 June. 2021.

  7. Chen, H.

    1. Chen, H. et al "FIZZ1 potentiates the carbachol-induced tracheal smooth muscle contraction." European Respiratory Journal 36.5 (2010): 1165-1173. Web. 21 June. 2021.

  8. Chetta, A.

    1. Crisafulli, E. et al "Efficacy of standard rehabilitation in COPD outpatients with comorbidities." European Respiratory Journal 36.5 (2010): 1042-1048. Web. 21 June. 2021.

  9. Chignard, M.

    1. Dif, F. et al "Critical role of cytosolic phospholipase A2α in bronchial mucus hypersecretion in CFTR-deficient mice." European Respiratory Journal 36.5 (2010): 1120-1130. Web. 21 June. 2021.

  10. Chuchalin, A.

    1. Bousquet, J. et al "Prioritised research agenda for prevention and control of chronic respiratory diseases." European Respiratory Journal 36.5 (2010): 995-1001. Web. 21 June. 2021.

  11. Clark, J.

    1. Solovic, I. et al "The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement." European Respiratory Journal 36.5 (2010): 1185-1206. Web. 21 June. 2021.

  12. Clini, E.M.

    1. Crisafulli, E. et al "Efficacy of standard rehabilitation in COPD outpatients with comorbidities." European Respiratory Journal 36.5 (2010): 1042-1048. Web. 21 June. 2021.

  13. Cohen, M.C.

    1. Edwards, C., R. Primhak, and M.C. Cohen. "Pulmonary alveolar proteinosis associated with Epstein–Barr virus infection." European Respiratory Journal 36.5 (2010): 1214-1216. Web. 21 June. 2021.

  14. Cohen-Kaminsky, S.

    1. Gambaryan, N. et al "Imatinib inhibits bone marrow-derived c-kit+ cell mobilisation in hypoxic pulmonary hypertension." European Respiratory Journal 36.5 (2010): 1209-1211. Web. 21 June. 2021.

  15. Corvinus, C.

    1. Corvinus, C. et al "Pulmonary hypertension in a patient with Abt–Letterer–Siwe syndrome and episodes of HAPE." European Respiratory Journal 36.5 (2010): 1212-1214. Web. 21 June. 2021.

  16. Costa, F.

    1. Crisafulli, E. et al "Efficacy of standard rehabilitation in COPD outpatients with comorbidities." European Respiratory Journal 36.5 (2010): 1042-1048. Web. 21 June. 2021.

  17. Cox-Ganser, J.

    1. Cummings, K.J. et al "Adverse respiratory outcomes associated with occupational exposures at a soy processing plant." European Respiratory Journal 36.5 (2010): 1007-1015. Web. 21 June. 2021.

  18. Crisafulli, E.

    1. Crisafulli, E. et al "Efficacy of standard rehabilitation in COPD outpatients with comorbidities." European Respiratory Journal 36.5 (2010): 1042-1048. Web. 21 June. 2021.

  19. Cruz, A.A.

    1. Bousquet, J. et al "Prioritised research agenda for prevention and control of chronic respiratory diseases." European Respiratory Journal 36.5 (2010): 995-1001. Web. 21 June. 2021.

  20. Cummings, K.J.

    1. Cummings, K.J. et al "Adverse respiratory outcomes associated with occupational exposures at a soy processing plant." European Respiratory Journal 36.5 (2010): 1007-1015. Web. 21 June. 2021.

D

  1. D'Angelo, M.G.

    1. Aliverti, A., A. Lo Mauro, and M.G. D'Angelo. "From the authors:." European Respiratory Journal 36.5 (2010): 1223. Web. 21 June. 2021.

  2. Damås, J.K.

    1. Eagan, T.M.L. et al "Body composition and plasma levels of inflammatory biomarkers in COPD." European Respiratory Journal 36.5 (2010): 1027-1033. Web. 21 June. 2021.

  3. Davies, J.

    1. Bush, A., and J. Davies. "Cystic fibrosis: to ion transport and beyond." European Respiratory Journal 36.5 (2010): 991-992. Web. 21 June. 2021.

  4. de Blasio, F.

    1. Crisafulli, E. et al "Efficacy of standard rehabilitation in COPD outpatients with comorbidities." European Respiratory Journal 36.5 (2010): 1042-1048. Web. 21 June. 2021.

  5. Dehnert, C.

    1. Corvinus, C. et al "Pulmonary hypertension in a patient with Abt–Letterer–Siwe syndrome and episodes of HAPE." European Respiratory Journal 36.5 (2010): 1212-1214. Web. 21 June. 2021.

  6. Derfuss, T.

    1. Sommer, N. et al "Mitochondrial cytochrome redox states and respiration in acute pulmonary oxygen sensing." European Respiratory Journal 36.5 (2010): 1056-1066. Web. 21 June. 2021.

  7. Diel, R.

    1. Solovic, I. et al "The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement." European Respiratory Journal 36.5 (2010): 1185-1206. Web. 21 June. 2021.

  8. Dif, F.

    1. Dif, F. et al "Critical role of cytosolic phospholipase A2α in bronchial mucus hypersecretion in CFTR-deficient mice." European Respiratory Journal 36.5 (2010): 1120-1130. Web. 21 June. 2021.

  9. Drazen, J.

    1. Bousquet, J. et al "Prioritised research agenda for prevention and control of chronic respiratory diseases." European Respiratory Journal 36.5 (2010): 995-1001. Web. 21 June. 2021.

  10. Duarte, R.

    1. Solovic, I. et al "The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement." European Respiratory Journal 36.5 (2010): 1185-1206. Web. 21 June. 2021.

E

  1. Eagan, T.M.L.

    1. Eagan, T.M.L. et al "Body composition and plasma levels of inflammatory biomarkers in COPD." European Respiratory Journal 36.5 (2010): 1027-1033. Web. 21 June. 2021.

  2. Edwards, C.

    1. Edwards, C., R. Primhak, and M.C. Cohen. "Pulmonary alveolar proteinosis associated with Epstein–Barr virus infection." European Respiratory Journal 36.5 (2010): 1214-1216. Web. 21 June. 2021.

  3. Ehlers, S.

    1. Solovic, I. et al "The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement." European Respiratory Journal 36.5 (2010): 1185-1206. Web. 21 June. 2021.

  4. Erkens, C.

    1. Solovic, I. et al "The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement." European Respiratory Journal 36.5 (2010): 1185-1206. Web. 21 June. 2021.

  5. Estela, A.

    1. Almirall, J. et al "Inhaled drugs as risk factors for community-acquired pneumonia." European Respiratory Journal 36.5 (2010): 1080-1087. Web. 21 June. 2021.

F

  1. Fabbri, L.M.

    1. Bousquet, J. et al "Prioritised research agenda for prevention and control of chronic respiratory diseases." European Respiratory Journal 36.5 (2010): 995-1001. Web. 21 June. 2021.
    2. Crisafulli, E. et al "Efficacy of standard rehabilitation in COPD outpatients with comorbidities." European Respiratory Journal 36.5 (2010): 1042-1048. Web. 21 June. 2021.

  2. Fano, V.

    1. Fano, V. et al "The fear of volcano: short-term health effects after Mount Etna's eruption in 2002." European Respiratory Journal 36.5 (2010): 1216-1218. Web. 21 June. 2021.

  3. Faoro, V.

    1. Naeije, R. et al "Pulmonary artery pressure limits exercise capacity at high altitude." European Respiratory Journal 36.5 (2010): 1049-1055. Web. 21 June. 2021.

  4. Folkerts, G.

    1. Mortaz, E. et al "Cigarette smoke induces CXCL8 production by human neutrophils via activation of TLR9 receptor." European Respiratory Journal 36.5 (2010): 1143-1154. Web. 21 June. 2021.

  5. Fontanals, D.

    1. Luján, M. et al "Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia." European Respiratory Journal 36.5 (2010): 1073-1079. Web. 21 June. 2021.

  6. Forastiere, F.

    1. Fano, V. et al "The fear of volcano: short-term health effects after Mount Etna's eruption in 2002." European Respiratory Journal 36.5 (2010): 1216-1218. Web. 21 June. 2021.

  7. Fukuoka, K.

    1. Tabata, C. et al "A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma." European Respiratory Journal 36.5 (2010): 1099-1105. Web. 21 June. 2021.

G

  1. Galiè, N.

    1. Galiè, N., M. Palazzini, and A. Manes. "Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed." European Respiratory Journal 36.5 (2010): 986-990. Web. 21 June. 2021.

  2. Gallego, M.

    1. Luján, M. et al "Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia." European Respiratory Journal 36.5 (2010): 1073-1079. Web. 21 June. 2021.

  3. Gambaryan, N.

    1. Gambaryan, N. et al "Imatinib inhibits bone marrow-derived c-kit+ cell mobilisation in hypoxic pulmonary hypertension." European Respiratory Journal 36.5 (2010): 1209-1211. Web. 21 June. 2021.

  4. Garcia-Verdugo, I.

    1. Dif, F. et al "Critical role of cytosolic phospholipase A2α in bronchial mucus hypersecretion in CFTR-deficient mice." European Respiratory Journal 36.5 (2010): 1120-1130. Web. 21 June. 2021.

  5. Gaschler, G.J.

    1. Gaschler, G.J. et al "Mechanisms of clearance of nontypeable Haemophilus influenzae from cigarette smoke-exposed mouse lungs." European Respiratory Journal 36.5 (2010): 1131-1142. Web. 21 June. 2021.

  6. Gaughan, D.M.

    1. Cummings, K.J. et al "Adverse respiratory outcomes associated with occupational exposures at a soy processing plant." European Respiratory Journal 36.5 (2010): 1007-1015. Web. 21 June. 2021.

  7. Gerbase, M.W.

    1. Bousquet, J. et al "Prioritised research agenda for prevention and control of chronic respiratory diseases." European Respiratory Journal 36.5 (2010): 995-1001. Web. 21 June. 2021.

  8. Gessler, T.

    1. Kiss, L. et al "Epoxyeicosatrienoates are the dominant eicosanoids in human lungs upon microbial challenge." European Respiratory Journal 36.5 (2010): 1088-1098. Web. 21 June. 2021.

  9. Ghofrani, H.A.

    1. Sommer, N. et al "Mitochondrial cytochrome redox states and respiration in acute pulmonary oxygen sensing." European Respiratory Journal 36.5 (2010): 1056-1066. Web. 21 June. 2021.

  10. Glader, P.

    1. Glader, P. et al "Interleukin-17-producing T-helper cells and related cytokines in human airways exposed to endotoxin." European Respiratory Journal 36.5 (2010): 1155-1164. Web. 21 June. 2021.

  11. Gnaiger, E.

    1. Sommer, N. et al "Mitochondrial cytochrome redox states and respiration in acute pulmonary oxygen sensing." European Respiratory Journal 36.5 (2010): 1056-1066. Web. 21 June. 2021.

  12. Goletti, D.

    1. Solovic, I. et al "The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement." European Respiratory Journal 36.5 (2010): 1185-1206. Web. 21 June. 2021.

  13. Gomez-Reino, J.J.

    1. Solovic, I. et al "The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement." European Respiratory Journal 36.5 (2010): 1185-1206. Web. 21 June. 2021.

  14. Gorgone, P.

    1. Crisafulli, E. et al "Efficacy of standard rehabilitation in COPD outpatients with comorbidities." European Respiratory Journal 36.5 (2010): 1042-1048. Web. 21 June. 2021.

  15. Green, B.J.

    1. Cummings, K.J. et al "Adverse respiratory outcomes associated with occupational exposures at a soy processing plant." European Respiratory Journal 36.5 (2010): 1007-1015. Web. 21 June. 2021.

  16. Grimminger, F.

    1. Sommer, N. et al "Mitochondrial cytochrome redox states and respiration in acute pulmonary oxygen sensing." European Respiratory Journal 36.5 (2010): 1056-1066. Web. 21 June. 2021.
    2. Kiss, L. et al "Epoxyeicosatrienoates are the dominant eicosanoids in human lungs upon microbial challenge." European Respiratory Journal 36.5 (2010): 1088-1098. Web. 21 June. 2021.

  17. Groves, R.

    1. Solovic, I. et al "The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement." European Respiratory Journal 36.5 (2010): 1185-1206. Web. 21 June. 2021.

  18. Grünig, E.

    1. Corvinus, C. et al "Pulmonary hypertension in a patient with Abt–Letterer–Siwe syndrome and episodes of HAPE." European Respiratory Journal 36.5 (2010): 1212-1214. Web. 21 June. 2021.

  19. Guarriello, V.

    1. Crisafulli, E. et al "Efficacy of standard rehabilitation in COPD outpatients with comorbidities." European Respiratory Journal 36.5 (2010): 1042-1048. Web. 21 June. 2021.

H

  1. Haahtela, T.

    1. Sistonen, S. et al "Repaired oesophageal atresia: respiratory morbidity and pulmonary function in adults." European Respiratory Journal 36.5 (2010): 1106-1112. Web. 21 June. 2021.

  2. Halbert, R.J.

    1. Lopez Varela, M.V. et al "Sex-related differences in COPD in five Latin American cities: the PLATINO study." European Respiratory Journal 36.5 (2010): 1034-1041. Web. 21 June. 2021.

  3. Hardie, J.A.

    1. Eagan, T.M.L. et al "Body composition and plasma levels of inflammatory biomarkers in COPD." European Respiratory Journal 36.5 (2010): 1027-1033. Web. 21 June. 2021.

  4. Hazenberg, A.

    1. Wijkstra, P., A. Hazenberg, and J. Nieuwenhuis. "Vital capacity in lying position: important in Duchenne patients." European Respiratory Journal 36.5 (2010): 1222. Web. 21 June. 2021.

  5. Heijink, I.H.

    1. Heijink, I.H., A. van Oosterhout, and A. Kapus. "Epidermal growth factor receptor signalling contributes to house dust mite-induced epithelial barrier dysfunction." European Respiratory Journal 36.5 (2010): 1016-1026. Web. 21 June. 2021.

  6. Heiskanen-Kosma, T.

    1. Heiskanen-Kosma, T., and M. Korppi. "Risk factors of community-acquired pneumonia in children." European Respiratory Journal 36.5 (2010): 1221-1222. Web. 21 June. 2021.

  7. Hellmich, B.

    1. Solovic, I. et al "The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement." European Respiratory Journal 36.5 (2010): 1185-1206. Web. 21 June. 2021.

  8. Herth, F.J.

    1. Corvinus, C. et al "Pulmonary hypertension in a patient with Abt–Letterer–Siwe syndrome and episodes of HAPE." European Respiratory Journal 36.5 (2010): 1212-1214. Web. 21 June. 2021.

  9. Hirayama, N.

    1. Tabata, C. et al "A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma." European Respiratory Journal 36.5 (2010): 1099-1105. Web. 21 June. 2021.

  10. Hoffmann, H.

    1. Nave, R. et al "Deposition and metabolism of inhaled ciclesonide in the human lung." European Respiratory Journal 36.5 (2010): 1113-1119. Web. 21 June. 2021.

  11. Hospital, I.

    1. Almirall, J. et al "Inhaled drugs as risk factors for community-acquired pneumonia." European Respiratory Journal 36.5 (2010): 1080-1087. Web. 21 June. 2021.

  12. Huckstorf, C.

    1. Sommer, N. et al "Mitochondrial cytochrome redox states and respiration in acute pulmonary oxygen sensing." European Respiratory Journal 36.5 (2010): 1056-1066. Web. 21 June. 2021.

  13. Huez, S.

    1. Naeije, R. et al "Pulmonary artery pressure limits exercise capacity at high altitude." European Respiratory Journal 36.5 (2010): 1049-1055. Web. 21 June. 2021.

  14. Humbert, M.

    1. Humbert, M.. "Update on the European Respiratory Review." European Respiratory Journal 36.5 (2010): 993-994. Web. 21 June. 2021.
    2. Bousquet, J. et al "Prioritised research agenda for prevention and control of chronic respiratory diseases." European Respiratory Journal 36.5 (2010): 995-1001. Web. 21 June. 2021.
    3. Gambaryan, N. et al "Imatinib inhibits bone marrow-derived c-kit+ cell mobilisation in hypoxic pulmonary hypertension." European Respiratory Journal 36.5 (2010): 1209-1211. Web. 21 June. 2021.

I

  1. Iida, S.

    1. Tabata, C. et al "A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma." European Respiratory Journal 36.5 (2010): 1099-1105. Web. 21 June. 2021.

  2. Israel-Biet, D.

    1. Dif, F. et al "Critical role of cytosolic phospholipase A2α in bronchial mucus hypersecretion in CFTR-deficient mice." European Respiratory Journal 36.5 (2010): 1120-1130. Web. 21 June. 2021.

  3. Ito, K.

    1. Mortaz, E. et al "Cigarette smoke induces CXCL8 production by human neutrophils via activation of TLR9 receptor." European Respiratory Journal 36.5 (2010): 1143-1154. Web. 21 June. 2021.

J

  1. Jacobson, B.A.

    1. Chen, H. et al "FIZZ1 potentiates the carbachol-induced tracheal smooth muscle contraction." European Respiratory Journal 36.5 (2010): 1165-1173. Web. 21 June. 2021.

  2. Jardim, J.R.B.

    1. Lopez Varela, M.V. et al "Sex-related differences in COPD in five Latin American cities: the PLATINO study." European Respiratory Journal 36.5 (2010): 1034-1041. Web. 21 June. 2021.

  3. Johannessen, A.

    1. Eagan, T.M.L. et al "Body composition and plasma levels of inflammatory biomarkers in COPD." European Respiratory Journal 36.5 (2010): 1027-1033. Web. 21 June. 2021.

  4. Joos, G.

    1. Bousquet, J. et al "Prioritised research agenda for prevention and control of chronic respiratory diseases." European Respiratory Journal 36.5 (2010): 995-1001. Web. 21 June. 2021.

K

  1. Kampmann, B.

    1. Solovic, I. et al "The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement." European Respiratory Journal 36.5 (2010): 1185-1206. Web. 21 June. 2021.

  2. Kapus, A.

    1. Heijink, I.H., A. van Oosterhout, and A. Kapus. "Epidermal growth factor receptor signalling contributes to house dust mite-induced epithelial barrier dysfunction." European Respiratory Journal 36.5 (2010): 1016-1026. Web. 21 June. 2021.

  3. Kataoka, K.

    1. Nishiyama, O. et al "A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis." European Respiratory Journal 36.5 (2010): 1067-1072. Web. 21 June. 2021.

  4. Kato, K.

    1. Nishiyama, O. et al "A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis." European Respiratory Journal 36.5 (2010): 1067-1072. Web. 21 June. 2021.

  5. Khaltaev, N.

    1. Bousquet, J. et al "Prioritised research agenda for prevention and control of chronic respiratory diseases." European Respiratory Journal 36.5 (2010): 995-1001. Web. 21 June. 2021.

  6. Kharitonov, S.A.

    1. Paredi, P. et al "In memoriam Michael Goldman (1936–2010)." European Respiratory Journal 36.5 (2010): 977-978. Web. 21 June. 2021.

  7. Kiley, J.

    1. Bousquet, J. et al "Prioritised research agenda for prevention and control of chronic respiratory diseases." European Respiratory Journal 36.5 (2010): 995-1001. Web. 21 June. 2021.

  8. Kimura, T.

    1. Nishiyama, O. et al "A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis." European Respiratory Journal 36.5 (2010): 1067-1072. Web. 21 June. 2021.

  9. Kiss, L.

    1. Kiss, L. et al "Epoxyeicosatrienoates are the dominant eicosanoids in human lungs upon microbial challenge." European Respiratory Journal 36.5 (2010): 1088-1098. Web. 21 June. 2021.

  10. Kita, Y.

    1. Dif, F. et al "Critical role of cytosolic phospholipase A2α in bronchial mucus hypersecretion in CFTR-deficient mice." European Respiratory Journal 36.5 (2010): 1120-1130. Web. 21 June. 2021.

  11. Kondoh, Y.

    1. Nishiyama, O. et al "A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis." European Respiratory Journal 36.5 (2010): 1067-1072. Web. 21 June. 2021.

  12. Korppi, M.

    1. Heiskanen-Kosma, T., and M. Korppi. "Risk factors of community-acquired pneumonia in children." European Respiratory Journal 36.5 (2010): 1221-1222. Web. 21 June. 2021.

  13. Kraneveld, A.D.

    1. Mortaz, E. et al "Cigarette smoke induces CXCL8 production by human neutrophils via activation of TLR9 receptor." European Respiratory Journal 36.5 (2010): 1143-1154. Web. 21 June. 2021.

  14. Kreiss, K.

    1. Cummings, K.J. et al "Adverse respiratory outcomes associated with occupational exposures at a soy processing plant." European Respiratory Journal 36.5 (2010): 1007-1015. Web. 21 June. 2021.

  15. Krug, A.

    1. Sommer, N. et al "Mitochondrial cytochrome redox states and respiration in acute pulmonary oxygen sensing." European Respiratory Journal 36.5 (2010): 1056-1066. Web. 21 June. 2021.

  16. Kullman, G.J.

    1. Cummings, K.J. et al "Adverse respiratory outcomes associated with occupational exposures at a soy processing plant." European Respiratory Journal 36.5 (2010): 1007-1015. Web. 21 June. 2021.

  17. Kuribayashi, K.

    1. Tabata, C. et al "A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma." European Respiratory Journal 36.5 (2010): 1099-1105. Web. 21 June. 2021.

L

  1. Lamotte, M.

    1. Naeije, R. et al "Pulmonary artery pressure limits exercise capacity at high altitude." European Respiratory Journal 36.5 (2010): 1049-1055. Web. 21 June. 2021.

  2. Lange, C.

    1. Solovic, I. et al "The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement." European Respiratory Journal 36.5 (2010): 1185-1206. Web. 21 June. 2021.

  3. Le, H.

    1. Lee, H.M. et al "Forced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality." European Respiratory Journal 36.5 (2010): 1002-1006. Web. 21 June. 2021.

  4. Leduc, D.

    1. Dif, F. et al "Critical role of cytosolic phospholipase A2α in bronchial mucus hypersecretion in CFTR-deficient mice." European Respiratory Journal 36.5 (2010): 1120-1130. Web. 21 June. 2021.

  5. Lee, B.T.

    1. Lee, H.M. et al "Forced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality." European Respiratory Journal 36.5 (2010): 1002-1006. Web. 21 June. 2021.

  6. Lee, H.M.

    1. Lee, H.M. et al "Forced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality." European Respiratory Journal 36.5 (2010): 1002-1006. Web. 21 June. 2021.

  7. LeSouëf, P.N.

    1. Zhang, G., and P.N. LeSouëf. "From Paul's predictions in the World Cup to the publication bias in genetic studies on complex traits." European Respiratory Journal 36.5 (2010): 1218-1219. Web. 21 June. 2021.

  8. Lindén, A.

    1. Glader, P. et al "Interleukin-17-producing T-helper cells and related cytokines in human airways exposed to endotoxin." European Respiratory Journal 36.5 (2010): 1155-1164. Web. 21 June. 2021.

  9. Lisboa, T.

    1. Luján, M. et al "Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia." European Respiratory Journal 36.5 (2010): 1073-1079. Web. 21 June. 2021.

  10. Lo Mauro, A.

    1. Aliverti, A., A. Lo Mauro, and M.G. D'Angelo. "From the authors:." European Respiratory Journal 36.5 (2010): 1223. Web. 21 June. 2021.

  11. Lopez, V.A.

    1. Lee, H.M. et al "Forced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality." European Respiratory Journal 36.5 (2010): 1002-1006. Web. 21 June. 2021.

  12. Lopez Varela, M.V.

    1. Lopez Varela, M.V. et al "Sex-related differences in COPD in five Latin American cities: the PLATINO study." European Respiratory Journal 36.5 (2010): 1034-1041. Web. 21 June. 2021.

  13. Luján, M.

    1. Luján, M. et al "Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia." European Respiratory Journal 36.5 (2010): 1073-1079. Web. 21 June. 2021.

M

  1. Magnussen, H.

    1. Nave, R. et al "Deposition and metabolism of inhaled ciclesonide in the human lung." European Respiratory Journal 36.5 (2010): 1113-1119. Web. 21 June. 2021.

  2. Makino, S.

    1. Bousquet, J. et al "Prioritised research agenda for prevention and control of chronic respiratory diseases." European Respiratory Journal 36.5 (2010): 995-1001. Web. 21 June. 2021.

  3. Malmberg, P.

    1. Sistonen, S. et al "Repaired oesophageal atresia: respiratory morbidity and pulmonary function in adults." European Respiratory Journal 36.5 (2010): 1106-1112. Web. 21 June. 2021.

  4. Malmhäll, C.

    1. Glader, P. et al "Interleukin-17-producing T-helper cells and related cytokines in human airways exposed to endotoxin." European Respiratory Journal 36.5 (2010): 1155-1164. Web. 21 June. 2021.

  5. Malmström, K.

    1. Sistonen, S. et al "Repaired oesophageal atresia: respiratory morbidity and pulmonary function in adults." European Respiratory Journal 36.5 (2010): 1106-1112. Web. 21 June. 2021.

  6. Manes, A.

    1. Galiè, N., M. Palazzini, and A. Manes. "Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed." European Respiratory Journal 36.5 (2010): 986-990. Web. 21 June. 2021.

  7. Marthan, R.

    1. Bara, I. et al "Pathophysiology of bronchial smooth muscle remodelling in asthma." European Respiratory Journal 36.5 (2010): 1174-1184. Web. 21 June. 2021.

  8. Martin, C.

    1. Dif, F. et al "Critical role of cytosolic phospholipase A2α in bronchial mucus hypersecretion in CFTR-deficient mice." European Respiratory Journal 36.5 (2010): 1120-1130. Web. 21 June. 2021.

  9. Masjedi, M.R.

    1. Bousquet, J. et al "Prioritised research agenda for prevention and control of chronic respiratory diseases." European Respiratory Journal 36.5 (2010): 995-1001. Web. 21 June. 2021.

  10. Mason, L.

    1. Chen, H. et al "FIZZ1 potentiates the carbachol-induced tracheal smooth muscle contraction." European Respiratory Journal 36.5 (2010): 1165-1173. Web. 21 June. 2021.

  11. Mayer, K.

    1. Kiss, L. et al "Epoxyeicosatrienoates are the dominant eicosanoids in human lungs upon microbial challenge." European Respiratory Journal 36.5 (2010): 1088-1098. Web. 21 June. 2021.

  12. Mazmanian, G.M.

    1. Gambaryan, N. et al "Imatinib inhibits bone marrow-derived c-kit+ cell mobilisation in hypoxic pulmonary hypertension." European Respiratory Journal 36.5 (2010): 1209-1211. Web. 21 June. 2021.

  13. Menezes, A.M.B.

    1. Lopez Varela, M.V. et al "Sex-related differences in COPD in five Latin American cities: the PLATINO study." European Respiratory Journal 36.5 (2010): 1034-1041. Web. 21 June. 2021.

  14. Migliori, G.B.

    1. van den Boom, M. et al "Finding the way through the respiratory symptoms jungle: PAL can help." European Respiratory Journal 36.5 (2010): 979-982. Web. 21 June. 2021.
    2. Solovic, I. et al "The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement." European Respiratory Journal 36.5 (2010): 1185-1206. Web. 21 June. 2021.

  15. Milburn, H.J.

    1. Solovic, I. et al "The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement." European Respiratory Journal 36.5 (2010): 1185-1206. Web. 21 June. 2021.

  16. Mollnes, T.E.

    1. Eagan, T.M.L. et al "Body composition and plasma levels of inflammatory biomarkers in COPD." European Respiratory Journal 36.5 (2010): 1027-1033. Web. 21 June. 2021.

  17. Montani, D.

    1. Gambaryan, N. et al "Imatinib inhibits bone marrow-derived c-kit+ cell mobilisation in hypoxic pulmonary hypertension." European Respiratory Journal 36.5 (2010): 1209-1211. Web. 21 June. 2021.

  18. Montes de Oca, M.

    1. Lopez Varela, M.V. et al "Sex-related differences in COPD in five Latin American cities: the PLATINO study." European Respiratory Journal 36.5 (2010): 1034-1041. Web. 21 June. 2021.

  19. Moreno, D.

    1. Lopez Varela, M.V. et al "Sex-related differences in COPD in five Latin American cities: the PLATINO study." European Respiratory Journal 36.5 (2010): 1034-1041. Web. 21 June. 2021.

  20. Mortaz, E.

    1. Mortaz, E. et al "Cigarette smoke induces CXCL8 production by human neutrophils via activation of TLR9 receptor." European Respiratory Journal 36.5 (2010): 1143-1154. Web. 21 June. 2021.

  21. Muiño, A.

    1. Lopez Varela, M.V. et al "Sex-related differences in COPD in five Latin American cities: the PLATINO study." European Respiratory Journal 36.5 (2010): 1034-1041. Web. 21 June. 2021.

  22. Murakami, A.

    1. Tabata, C. et al "A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma." European Respiratory Journal 36.5 (2010): 1099-1105. Web. 21 June. 2021.

N

  1. Naeije, R.

    1. Naeije, R. et al "Pulmonary artery pressure limits exercise capacity at high altitude." European Respiratory Journal 36.5 (2010): 1049-1055. Web. 21 June. 2021.

  2. Nakano, T.

    1. Tabata, C. et al "A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma." European Respiratory Journal 36.5 (2010): 1099-1105. Web. 21 June. 2021.

  3. Nave, R.

    1. Nave, R. et al "Deposition and metabolism of inhaled ciclesonide in the human lung." European Respiratory Journal 36.5 (2010): 1113-1119. Web. 21 June. 2021.

  4. Neupane, S.

    1. Naeije, R. et al "Pulmonary artery pressure limits exercise capacity at high altitude." European Respiratory Journal 36.5 (2010): 1049-1055. Web. 21 June. 2021.

  5. Nieuwenhuis, J.

    1. Wijkstra, P., A. Hazenberg, and J. Nieuwenhuis. "Vital capacity in lying position: important in Duchenne patients." European Respiratory Journal 36.5 (2010): 1222. Web. 21 June. 2021.

  6. Nijkamp, F.P.

    1. Mortaz, E. et al "Cigarette smoke induces CXCL8 production by human neutrophils via activation of TLR9 receptor." European Respiratory Journal 36.5 (2010): 1143-1154. Web. 21 June. 2021.

  7. Nishiyama, O.

    1. Nishiyama, O. et al "A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis." European Respiratory Journal 36.5 (2010): 1067-1072. Web. 21 June. 2021.

O

  1. Ogawa, T.

    1. Nishiyama, O. et al "A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis." European Respiratory Journal 36.5 (2010): 1067-1072. Web. 21 June. 2021.

  2. Olivieri, D.

    1. Crisafulli, E. et al "Efficacy of standard rehabilitation in COPD outpatients with comorbidities." European Respiratory Journal 36.5 (2010): 1042-1048. Web. 21 June. 2021.

  3. Ollero, M.

    1. Dif, F. et al "Critical role of cytosolic phospholipase A2α in bronchial mucus hypersecretion in CFTR-deficient mice." European Respiratory Journal 36.5 (2010): 1120-1130. Web. 21 June. 2021.

  4. Ottmani, S.

    1. van den Boom, M. et al "Finding the way through the respiratory symptoms jungle: PAL can help." European Respiratory Journal 36.5 (2010): 979-982. Web. 21 June. 2021.

  5. Ozier, A.

    1. Bara, I. et al "Pathophysiology of bronchial smooth muscle remodelling in asthma." European Respiratory Journal 36.5 (2010): 1174-1184. Web. 21 June. 2021.

P

  1. Padberg, W.

    1. Kiss, L. et al "Epoxyeicosatrienoates are the dominant eicosanoids in human lungs upon microbial challenge." European Respiratory Journal 36.5 (2010): 1088-1098. Web. 21 June. 2021.

  2. Pagani, M.

    1. Crisafulli, E. et al "Efficacy of standard rehabilitation in COPD outpatients with comorbidities." European Respiratory Journal 36.5 (2010): 1042-1048. Web. 21 June. 2021.

  3. Paggiaro, P.

    1. Crisafulli, E. et al "Efficacy of standard rehabilitation in COPD outpatients with comorbidities." European Respiratory Journal 36.5 (2010): 1042-1048. Web. 21 June. 2021.

  4. Pak, O.

    1. Sommer, N. et al "Mitochondrial cytochrome redox states and respiration in acute pulmonary oxygen sensing." European Respiratory Journal 36.5 (2010): 1056-1066. Web. 21 June. 2021.

  5. Pakarinen, M.P.

    1. Sistonen, S. et al "Repaired oesophageal atresia: respiratory morbidity and pulmonary function in adults." European Respiratory Journal 36.5 (2010): 1106-1112. Web. 21 June. 2021.

  6. Palazzini, M.

    1. Galiè, N., M. Palazzini, and A. Manes. "Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed." European Respiratory Journal 36.5 (2010): 986-990. Web. 21 June. 2021.

  7. Palomera, E.

    1. Almirall, J. et al "Inhaled drugs as risk factors for community-acquired pneumonia." European Respiratory Journal 36.5 (2010): 1080-1087. Web. 21 June. 2021.

  8. Papanikolaou, I.C.

    1. Papanikolaou, I.C., and O.P. Sharma. "The relationship between sarcoidosis and lymphoma." European Respiratory Journal 36.5 (2010): 1207-1219. Web. 21 June. 2021.

  9. Paredi, P.

    1. Paredi, P. et al "In memoriam Michael Goldman (1936–2010)." European Respiratory Journal 36.5 (2010): 977-978. Web. 21 June. 2021.

  10. Perez-Padilla, R.

    1. Lopez Varela, M.V. et al "Sex-related differences in COPD in five Latin American cities: the PLATINO study." European Respiratory Journal 36.5 (2010): 1034-1041. Web. 21 June. 2021.

  11. Perros, F.

    1. Gambaryan, N. et al "Imatinib inhibits bone marrow-derived c-kit+ cell mobilisation in hypoxic pulmonary hypertension." European Respiratory Journal 36.5 (2010): 1209-1211. Web. 21 June. 2021.

  12. Pertuzé, J.

    1. Lopez Varela, M.V. et al "Sex-related differences in COPD in five Latin American cities: the PLATINO study." European Respiratory Journal 36.5 (2010): 1034-1041. Web. 21 June. 2021.

  13. Perucci, C.A.

    1. Fano, V. et al "The fear of volcano: short-term health effects after Mount Etna's eruption in 2002." European Respiratory Journal 36.5 (2010): 1216-1218. Web. 21 June. 2021.

  14. Pride, N.B.

    1. Paredi, P. et al "In memoriam Michael Goldman (1936–2010)." European Respiratory Journal 36.5 (2010): 977-978. Web. 21 June. 2021.

  15. Primhak, R.

    1. Edwards, C., R. Primhak, and M.C. Cohen. "Pulmonary alveolar proteinosis associated with Epstein–Barr virus infection." European Respiratory Journal 36.5 (2010): 1214-1216. Web. 21 June. 2021.

Q

  1. Qvarfordt, I.

    1. Glader, P. et al "Interleukin-17-producing T-helper cells and related cytokines in human airways exposed to endotoxin." European Respiratory Journal 36.5 (2010): 1155-1164. Web. 21 June. 2021.

R

  1. Rabe, K.

    1. Bousquet, J. et al "Prioritised research agenda for prevention and control of chronic respiratory diseases." European Respiratory Journal 36.5 (2010): 995-1001. Web. 21 June. 2021.

  2. Ravn, P.

    1. Solovic, I. et al "The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement." European Respiratory Journal 36.5 (2010): 1185-1206. Web. 21 June. 2021.

  3. Rello, J.

    1. Luján, M. et al "Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia." European Respiratory Journal 36.5 (2010): 1073-1079. Web. 21 June. 2021.

  4. Retailleau, K.

    1. Naeije, R. et al "Pulmonary artery pressure limits exercise capacity at high altitude." European Respiratory Journal 36.5 (2010): 1049-1055. Web. 21 June. 2021.

  5. Rieder, H.L.

    1. Solovic, I. et al "The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement." European Respiratory Journal 36.5 (2010): 1185-1206. Web. 21 June. 2021.

  6. Rintala, R.J.

    1. Sistonen, S. et al "Repaired oesophageal atresia: respiratory morbidity and pulmonary function in adults." European Respiratory Journal 36.5 (2010): 1106-1112. Web. 21 June. 2021.

  7. Rohde, G.G.U.

    1. Rohde, G.G.U.. "Prudent use of antibiotics: acute exacerbation of COPD as an example." European Respiratory Journal 36.5 (2010): 983-985. Web. 21 June. 2021.

  8. Roig, J.

    1. Almirall, J. et al "Inhaled drugs as risk factors for community-acquired pneumonia." European Respiratory Journal 36.5 (2010): 1080-1087. Web. 21 June. 2021.

  9. Rossi, G.

    1. Crisafulli, E. et al "Efficacy of standard rehabilitation in COPD outpatients with comorbidities." European Respiratory Journal 36.5 (2010): 1042-1048. Web. 21 June. 2021.

S

  1. Sarna, S.

    1. Sistonen, S. et al "Repaired oesophageal atresia: respiratory morbidity and pulmonary function in adults." European Respiratory Journal 36.5 (2010): 1106-1112. Web. 21 June. 2021.

  2. Schermuly, R.T.

    1. Sommer, N. et al "Mitochondrial cytochrome redox states and respiration in acute pulmonary oxygen sensing." European Respiratory Journal 36.5 (2010): 1056-1066. Web. 21 June. 2021.

  3. Scholte, B.J.

    1. Dif, F. et al "Critical role of cytosolic phospholipase A2α in bronchial mucus hypersecretion in CFTR-deficient mice." European Respiratory Journal 36.5 (2010): 1120-1130. Web. 21 June. 2021.

  4. Schölvinck, E.H.

    1. Solovic, I. et al "The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement." European Respiratory Journal 36.5 (2010): 1185-1206. Web. 21 June. 2021.

  5. Schörner, S.

    1. Sommer, N. et al "Mitochondrial cytochrome redox states and respiration in acute pulmonary oxygen sensing." European Respiratory Journal 36.5 (2010): 1056-1066. Web. 21 June. 2021.

  6. Schreiber, S.

    1. Solovic, I. et al "The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement." European Respiratory Journal 36.5 (2010): 1185-1206. Web. 21 June. 2021.

  7. Schütte, H.

    1. Kiss, L. et al "Epoxyeicosatrienoates are the dominant eicosanoids in human lungs upon microbial challenge." European Respiratory Journal 36.5 (2010): 1088-1098. Web. 21 June. 2021.

  8. Scondotto, S.

    1. Fano, V. et al "The fear of volcano: short-term health effects after Mount Etna's eruption in 2002." European Respiratory Journal 36.5 (2010): 1216-1218. Web. 21 June. 2021.

  9. Seeger, W.

    1. Sommer, N. et al "Mitochondrial cytochrome redox states and respiration in acute pulmonary oxygen sensing." European Respiratory Journal 36.5 (2010): 1056-1066. Web. 21 June. 2021.
    2. Kiss, L. et al "Epoxyeicosatrienoates are the dominant eicosanoids in human lungs upon microbial challenge." European Respiratory Journal 36.5 (2010): 1088-1098. Web. 21 June. 2021.

  10. Seita, A.

    1. van den Boom, M. et al "Finding the way through the respiratory symptoms jungle: PAL can help." European Respiratory Journal 36.5 (2010): 979-982. Web. 21 June. 2021.

  11. Serra-Prat, M.

    1. Almirall, J. et al "Inhaled drugs as risk factors for community-acquired pneumonia." European Respiratory Journal 36.5 (2010): 1080-1087. Web. 21 June. 2021.

  12. Sester, M.

    1. Solovic, I. et al "The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement." European Respiratory Journal 36.5 (2010): 1185-1206. Web. 21 June. 2021.

  13. Sharma, O.P.

    1. Papanikolaou, I.C., and O.P. Sharma. "The relationship between sarcoidosis and lymphoma." European Respiratory Journal 36.5 (2010): 1207-1219. Web. 21 June. 2021.

  14. Siafakas, N.M.

    1. Paredi, P. et al "In memoriam Michael Goldman (1936–2010)." European Respiratory Journal 36.5 (2010): 977-978. Web. 21 June. 2021.

  15. Sistonen, S.

    1. Sistonen, S. et al "Repaired oesophageal atresia: respiratory morbidity and pulmonary function in adults." European Respiratory Journal 36.5 (2010): 1106-1112. Web. 21 June. 2021.

  16. Sjöstrand, M.

    1. Glader, P. et al "Interleukin-17-producing T-helper cells and related cytokines in human airways exposed to endotoxin." European Respiratory Journal 36.5 (2010): 1155-1164. Web. 21 June. 2021.

  17. Smith, M.E.

    1. Glader, P. et al "Interleukin-17-producing T-helper cells and related cytokines in human airways exposed to endotoxin." European Respiratory Journal 36.5 (2010): 1155-1164. Web. 21 June. 2021.

  18. Solovic, I.

    1. Solovic, I. et al "The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement." European Respiratory Journal 36.5 (2010): 1185-1206. Web. 21 June. 2021.

  19. Sommer, N.

    1. Sommer, N. et al "Mitochondrial cytochrome redox states and respiration in acute pulmonary oxygen sensing." European Respiratory Journal 36.5 (2010): 1056-1066. Web. 21 June. 2021.

  20. Sotgiu, G.

    1. Solovic, I. et al "The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement." European Respiratory Journal 36.5 (2010): 1185-1206. Web. 21 June. 2021.

  21. Stämpfli, M.R.

    1. Gaschler, G.J. et al "Mechanisms of clearance of nontypeable Haemophilus influenzae from cigarette smoke-exposed mouse lungs." European Respiratory Journal 36.5 (2010): 1131-1142. Web. 21 June. 2021.

T

  1. Tabata, C.

    1. Tabata, C. et al "A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma." European Respiratory Journal 36.5 (2010): 1099-1105. Web. 21 June. 2021.

  2. Tabata, R.

    1. Tabata, C. et al "A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma." European Respiratory Journal 36.5 (2010): 1099-1105. Web. 21 June. 2021.

  3. Tálamo, C.

    1. Lopez Varela, M.V. et al "Sex-related differences in COPD in five Latin American cities: the PLATINO study." European Respiratory Journal 36.5 (2010): 1034-1041. Web. 21 June. 2021.

  4. Tamura, K.

    1. Tabata, C. et al "A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma." European Respiratory Journal 36.5 (2010): 1099-1105. Web. 21 June. 2021.

  5. Taniguchi, H.

    1. Nishiyama, O. et al "A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis." European Respiratory Journal 36.5 (2010): 1067-1072. Web. 21 June. 2021.

  6. Terada, T.

    1. Tabata, C. et al "A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma." European Respiratory Journal 36.5 (2010): 1099-1105. Web. 21 June. 2021.

  7. To, T.

    1. Bousquet, J. et al "Prioritised research agenda for prevention and control of chronic respiratory diseases." European Respiratory Journal 36.5 (2010): 995-1001. Web. 21 June. 2021.

  8. Torres, A.

    1. Almirall, J. et al "Inhaled drugs as risk factors for community-acquired pneumonia." European Respiratory Journal 36.5 (2010): 1080-1087. Web. 21 June. 2021.

  9. Touqui, L.

    1. Dif, F. et al "Critical role of cytosolic phospholipase A2α in bronchial mucus hypersecretion in CFTR-deficient mice." European Respiratory Journal 36.5 (2010): 1120-1130. Web. 21 June. 2021.

  10. Tunon de Lara, J-M.

    1. Bara, I. et al "Pathophysiology of bronchial smooth muscle remodelling in asthma." European Respiratory Journal 36.5 (2010): 1174-1184. Web. 21 June. 2021.

U

  1. Ueland, T.

    1. Eagan, T.M.L. et al "Body composition and plasma levels of inflammatory biomarkers in COPD." European Respiratory Journal 36.5 (2010): 1027-1033. Web. 21 June. 2021.

  2. Usmani, O.S.

    1. Paredi, P. et al "In memoriam Michael Goldman (1936–2010)." European Respiratory Journal 36.5 (2010): 977-978. Web. 21 June. 2021.

V

  1. Vagaggini, B.

    1. Crisafulli, E. et al "Efficacy of standard rehabilitation in COPD outpatients with comorbidities." European Respiratory Journal 36.5 (2010): 1042-1048. Web. 21 June. 2021.

  2. Valdivia, G.

    1. Lopez Varela, M.V. et al "Sex-related differences in COPD in five Latin American cities: the PLATINO study." European Respiratory Journal 36.5 (2010): 1034-1041. Web. 21 June. 2021.

  3. Vallès, J.

    1. Luján, M. et al "Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia." European Respiratory Journal 36.5 (2010): 1073-1079. Web. 21 June. 2021.

  4. van den Boom, M.

    1. van den Boom, M. et al "Finding the way through the respiratory symptoms jungle: PAL can help." European Respiratory Journal 36.5 (2010): 979-982. Web. 21 June. 2021.

  5. van Oosterhout, A.

    1. Heijink, I.H., A. van Oosterhout, and A. Kapus. "Epidermal growth factor receptor signalling contributes to house dust mite-induced epithelial barrier dysfunction." European Respiratory Journal 36.5 (2010): 1016-1026. Web. 21 June. 2021.

  6. Van Oosterhout, A.J.M.

    1. Birrell, M.A., A.J.M. Van Oosterhout, and M.G. Belvisi. "Do the current house dust mite-driven models really mimic allergic asthma?." European Respiratory Journal 36.5 (2010): 1220-1221. Web. 21 June. 2021.

  7. Viegi, G.

    1. Bousquet, J. et al "Prioritised research agenda for prevention and control of chronic respiratory diseases." European Respiratory Journal 36.5 (2010): 995-1001. Web. 21 June. 2021.

  8. Voswinckel, R.

    1. Kiss, L. et al "Epoxyeicosatrienoates are the dominant eicosanoids in human lungs upon microbial challenge." European Respiratory Journal 36.5 (2010): 1088-1098. Web. 21 June. 2021.

W

  1. Wagner, P.D.

    1. Eagan, T.M.L. et al "Body composition and plasma levels of inflammatory biomarkers in COPD." European Respiratory Journal 36.5 (2010): 1027-1033. Web. 21 June. 2021.

  2. Wallis, R.S.

    1. Solovic, I. et al "The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement." European Respiratory Journal 36.5 (2010): 1185-1206. Web. 21 June. 2021.

  3. Watanabe, F.

    1. Nishiyama, O. et al "A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis." European Respiratory Journal 36.5 (2010): 1067-1072. Web. 21 June. 2021.

  4. Watz, H.

    1. Nave, R. et al "Deposition and metabolism of inhaled ciclesonide in the human lung." European Respiratory Journal 36.5 (2010): 1113-1119. Web. 21 June. 2021.

  5. Weissmann, N.

    1. Sommer, N. et al "Mitochondrial cytochrome redox states and respiration in acute pulmonary oxygen sensing." European Respiratory Journal 36.5 (2010): 1056-1066. Web. 21 June. 2021.
    2. Kiss, L. et al "Epoxyeicosatrienoates are the dominant eicosanoids in human lungs upon microbial challenge." European Respiratory Journal 36.5 (2010): 1088-1098. Web. 21 June. 2021.

  6. Wijkstra, P.

    1. Wijkstra, P., A. Hazenberg, and J. Nieuwenhuis. "Vital capacity in lying position: important in Duchenne patients." European Respiratory Journal 36.5 (2010): 1222. Web. 21 June. 2021.

  7. Wolf, S.F.

    1. Chen, H. et al "FIZZ1 potentiates the carbachol-induced tracheal smooth muscle contraction." European Respiratory Journal 36.5 (2010): 1165-1173. Web. 21 June. 2021.

  8. Wong, N.D.

    1. Lee, H.M. et al "Forced vital capacity paired with Framingham Risk Score for prediction of all-cause mortality." European Respiratory Journal 36.5 (2010): 1002-1006. Web. 21 June. 2021.

  9. Wu, Y-Z.

    1. Dif, F. et al "Critical role of cytosolic phospholipase A2α in bronchial mucus hypersecretion in CFTR-deficient mice." European Respiratory Journal 36.5 (2010): 1120-1130. Web. 21 June. 2021.

Y

  1. Yamada, S.

    1. Tabata, C. et al "A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma." European Respiratory Journal 36.5 (2010): 1099-1105. Web. 21 June. 2021.

  2. Yasumitsu, A.

    1. Tabata, C. et al "A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma." European Respiratory Journal 36.5 (2010): 1099-1105. Web. 21 June. 2021.

Z

  1. Zavitz, C.C.J.

    1. Gaschler, G.J. et al "Mechanisms of clearance of nontypeable Haemophilus influenzae from cigarette smoke-exposed mouse lungs." European Respiratory Journal 36.5 (2010): 1131-1142. Web. 21 June. 2021.

  2. Zellweger, J.P.

    1. Solovic, I. et al "The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement." European Respiratory Journal 36.5 (2010): 1185-1206. Web. 21 June. 2021.

  3. Zhang, G.

    1. Zhang, G., and P.N. LeSouëf. "From Paul's predictions in the World Cup to the publication bias in genetic studies on complex traits." European Respiratory Journal 36.5 (2010): 1218-1219. Web. 21 June. 2021.

  4. Zhi, L.

    1. Bousquet, J. et al "Prioritised research agenda for prevention and control of chronic respiratory diseases." European Respiratory Journal 36.5 (2010): 995-1001. Web. 21 June. 2021.
Back to top
European Respiratory Journal: 36 (5)

Search Within This Issue

Jump to

Manage Table of content Alerts